We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 30, 2022

Impact of the ARUBA Trial on Trends and Outcomes in Patients With Symptomatic Nonruptured Brain AVMs

Journal of Stroke & Cerebrovascular Diseases


Additional Info

Journal of Stroke & Cerebrovascular Diseases
Impact of ARUBA trial on trends and outcomes in symptomatic non-ruptured brain AVMs: A national sample analysis
J Stroke Cerebrovasc Dis 2022 Dec 01;31(12)106807, SD Patel, H Saber, N Desai, FO Otite, N Kaneko, TV Mehta, J Hinman, AE Hassan, A Jadhav, DS Liebeskind, JL Saver

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading